Top 50 Orbimed Advisors Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| EWTX | EDGEWISE THERAPEUTICS INC | 10.66% | 15.52M | $488.8M | +0.00%(+0) | $30.57(+29.42%) | 2026-03-31 | |
| ELVN | ENLIVEN THERAPEUTICS INC | 6.8% | 7.96M | $312.0M | +0.00%(+0) | $19.13(+160.42%) | 2026-03-31 | |
| LLY | ELI LILLY & CO | 4.75% | 236.8K | $217.8M | -21.38%(-64.40K) | $455.47(+166.52%) | 2026-03-31 | |
| SVA | SINOVAC BIOTECH LTD | 4.02% | 2.72M | $184.5M | +0.00%(+0) | $4.33(+49.41%) | 2026-03-31 | |
| BSX | BOSTON SCIENTIFIC CORP | 3.26% | 2.38M | $149.5M | -1.54%(-37.20K) | $25.59(+76.40%) | 2026-03-31 | |
| SION | SIONNA THERAPEUTICS INC | 3.09% | 3.53M | $141.5M | -0.87%(-30.95K) | $10.46(+320.55%) | 2026-03-31 | |
| AZN | ASTRAZENECA PLC | 2.88% | 670.2K | $132.2M | new | $190.54(+2.42%) | 2026-03-31 | |
| MYGN | MYRIAD GENETICS INC | 2.68% | 125.00M | $122.9M | new | $5.33(+12.49%) | 2026-03-31 | |
| MBX | MBX BIOSCIENCES INC | 2.37% | 3.64M | $108.6M | -7.56%(-297.32K) | $25.36(+127.94%) | 2026-03-31 | |
| CRVS | CORVUS PHARMACEUTICALS INC | 2.29% | 7.17M | $104.8M | +0.00%(+0) | $11.17(+36.36%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +7.01% | +22.52% |
| Top 20 Holdings Unweighted | +9.25% | +30.41% |
Sign up free to track Orbimed Advisors Llc, compare funds side by side, and get alerts the moment positions change.